CIK 1113481

MEDICINES CO /DE

EDGAR filings

Customers

None disclosed

Suppliers

0 disclosed

Latest period

Dec 31, 2017

10-K filed 2018-02-26

Suppliers 1

Companies that disclose MEDICINES CO /DE as a major customer, as a share of their own revenue. 0 active, 1 lapsed.

Company	% of their revenue	Est. $ from MEDICINES CO /DE	Period	Trend	Status	Source
EAGLE PHARMACEUTICALS, INC. EAGLE PHARMACEUTICALS, INC.	2%	$4.7M	FY 2017-12-31	−2.0pp	Lapsed Last seen 2017-12-31	10-K 2018-02-26
The Medicines Company /Chiesi USA, Inc. 2 % 4 % 14 % 10-K filed 2018-02-26 Period FY 2017-01-01 to 2017-12-31 (2%), FY 2016-01-01 to 2016-12-31 (4%)Accession 0000827871-18-000003 Chiesi USA, Inc. / The Medicines Company 3 % 4 % 3 % 5 % 10-Q filed 2017-08-09 Period 3M 2017-04-01 to 2017-06-30 (3%), 3M 2016-04-01 to 2016-06-30 (4%)Accession 0000827871-17-000007 The Medicines Company/Chiesi USA, Inc. 4 % 6 % 10-Q filed 2017-05-08 Period 3M 2017-01-01 to 2017-03-31 (4%), 3M 2016-01-01 to 2016-03-31 (6%)Accession 0000827871-17-000004 The Medicines Company/Chiesi USA, Inc. 5 % 37 % 6 % 15 % 10-Q filed 2016-11-09 Period 3M 2016-07-01 to 2016-09-30 (5%), 3M 2015-07-01 to 2015-09-30 (37%)Accession 0000827871-16-000080 The Medicines Company 4 % 37 % 5 % 13 % 10-Q filed 2016-08-09 Period 3M 2015-04-01 to 2015-06-30 (37%)Accession 0000827871-16-000074 The Medicines Company 37 % 50 % 15 % 26 % 10-Q filed 2015-11-12 Period 3M 2014-07-01 to 2014-09-30 (50%)Accession 0000827871-15-000047 The Medicines Company 37 % 13 % 13 % 20 % 10-Q filed 2015-08-11 Period 3M 2014-04-01 to 2014-06-30 (13%)Accession 0000827871-15-000042

Unnamed major customers

Disclosed without names in the fiscal year ending 2017-12-31. Identities are not inferred.

Sandoz55%
Integrated Commercialization Solutions Inc5%

Alerts are coming

Get an email when MEDICINES CO /DE's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.